Literature DB >> 24807392

β1 integrin modulates tumor growth and apoptosis of human colorectal cancer.

Jia Song1, Jixiang Zhang1, Jing Wang1, Zhuo Cao1, Jun Wang1, Xufeng Guo1, Weiguo Dong1.   

Abstract

We aimed to ascertain whether β1 integrin (ITGB1) induces apoptosis of colorectal cancer (CRC) through regulation of the mitochondrial pathway in vitro and in vivo. We generated lentiviral vectors expressing ITGB1 or ITGB1-specific RNAi and an unrelated control vector. After infection of the HT29 cells, we used western blot analysis and flow cytometric analysis to validate the patterns of ITGB1 expression. Proliferation and apoptosis were evaluated by colony formation assay, flow cytometry and western blot analysis. Upregulation of ITGB1 significantly increased the proliferation of HT29 cells; however, the levels of Bcl-2 and cyclin D1 proteins were upregulated while Bax, caspase-3, caspase-9 and p21 were downregulated in the HT29-ITGB1 cells compared to these levels in the controls. Hoechst 33258 staining and flow cytometric analysis showed that ITGB1 may play a significant role in the apoptosis of CRC cells. Moreover, ITGB1 promoted the proliferation of cells in a xenograft tumor mouse model. TUNEL staining revealed a marked increase in the percentage of positive cells in the HT29-RNAi group (84.3 ± 4.0%), which were more significant than in the HT29-ITGB1 group (48.3 ± 2.9%) and the other two control groups, HT29 (52.0 ± 3.6%) and HT29-NC (49.7 ± 4.5%). These results suggest that ITGB1 regulates the growth and apoptosis of human colorectal cancer cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24807392     DOI: 10.3892/or.2014.3168

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Does rarity mean imparity? Biological characteristics of osteosarcoma cells originating from the spine.

Authors:  Zhenhua Zhou; Yan Li; Xu Yan; Xudong Wang; Cheng Yang; Haifeng Wei; Xinghai Yang; Jianru Xiao
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-27       Impact factor: 4.553

2.  Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification.

Authors:  Christopher J Hayes; Catriona M Dowling; Susan Dwane; Mary E McCumiskey; Shona M Tormey; B Anne Merrigan; John C Coffey; Patrick A Kiely; Tara M Dalton
Journal:  Biomicrofluidics       Date:  2016-10-31       Impact factor: 2.800

3.  Hypoxia-inducible ERO1α promotes cancer progression through modulation of integrin-β1 modification and signalling in HCT116 colorectal cancer cells.

Authors:  Norio Takei; Akihiro Yoneda; Kaori Sakai-Sawada; Marina Kosaka; Kenjiro Minomi; Yasuaki Tamura
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

4.  Proteomic Level Changes on Treatment in MCF-7/DDP Breast Cancer Drug- Resistant Cells.

Authors:  Gongshen Jin; Kangwei Wang; Yonghong Liu; Xianhu Liu; Xiaojing Zhang; Hao Zhang
Journal:  Anticancer Agents Med Chem       Date:  2020       Impact factor: 2.505

5.  ITGB1 Drives Hepatocellular Carcinoma Progression by Modulating Cell Cycle Process Through PXN/YWHAZ/AKT Pathways.

Authors:  Jinghe Xie; Tingting Guo; Zhiyong Zhong; Ning Wang; Yan Liang; Weiping Zeng; Shoupei Liu; Qicong Chen; Xianglian Tang; Haibin Wu; Shuai Zhang; Keqiang Ma; Bailin Wang; Yimeng Ou; Weili Gu; Honglin Chen; Yaqi Qiu; Yuyou Duan
Journal:  Front Cell Dev Biol       Date:  2021-12-17

6.  2-Methoxy-1,4-naphthoquinone (MNQ) regulates cancer key genes of MAPK, PI3K, and NF-κB pathways in Raji cells.

Authors:  Teck Yew Wong; Subramaniam Menaga; Chi-Ying F Huang; Siong Hock Anthony Ho; Seng Chiew Gan; Yang Mooi Lim
Journal:  Genomics Inform       Date:  2022-03-31

7.  Midkine is neuroprotective and influences glial reactivity and the formation of Müller glia-derived progenitor cells in chick and mouse retinas.

Authors:  Warren A Campbell; Amanda Fritsch-Kelleher; Isabella Palazzo; Thanh Hoang; Seth Blackshaw; Andy J Fischer
Journal:  Glia       Date:  2021-02-10       Impact factor: 7.452

8.  Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.

Authors:  Lei Zhang; Wen Zou
Journal:  Mol Med Rep       Date:  2015-10-14       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.